These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
641 related items for PubMed ID: 25652202
1. Dual-targeting of aberrant glucose metabolism in glioblastoma. Shen H, Decollogne S, Dilda PJ, Hau E, Chung SA, Luk PP, Hogg PJ, McDonald KL. J Exp Clin Cancer Res; 2015 Feb 05; 34(1):14. PubMed ID: 25652202 [Abstract] [Full Text] [Related]
2. Targeting of two aspects of metabolism in breast cancer treatment. Gang BP, Dilda PJ, Hogg PJ, Blackburn AC. Cancer Biol Ther; 2014 Feb 05; 15(11):1533-41. PubMed ID: 25482950 [Abstract] [Full Text] [Related]
3. Alterations in the mitochondrial responses to PENAO as a mechanism of resistance in ovarian cancer cells. Decollogne S, Joshi S, Chung SA, Luk PP, Yeo RX, Nixdorf S, Fedier A, Heinzelmann-Schwarz V, Hogg PJ, Dilda PJ. Gynecol Oncol; 2015 Aug 05; 138(2):363-71. PubMed ID: 26080289 [Abstract] [Full Text] [Related]
4. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer. Roh JL, Park JY, Kim EH, Jang HJ, Kwon M. Cancer Lett; 2016 Feb 01; 371(1):20-9. PubMed ID: 26607904 [Abstract] [Full Text] [Related]
5. Sensitization of Glioblastoma Cells to Irradiation by Modulating the Glucose Metabolism. Shen H, Hau E, Joshi S, Dilda PJ, McDonald KL. Mol Cancer Ther; 2015 Aug 01; 14(8):1794-804. PubMed ID: 26063767 [Abstract] [Full Text] [Related]
6. Antitumor and chemosensitizing action of dichloroacetate implicates modulation of tumor microenvironment: a role of reorganized glucose metabolism, cell survival regulation and macrophage differentiation. Kumar A, Kant S, Singh SM. Toxicol Appl Pharmacol; 2013 Nov 15; 273(1):196-208. PubMed ID: 24051182 [Abstract] [Full Text] [Related]
7. Metabolic modulation of glioblastoma with dichloroacetate. Michelakis ED, Sutendra G, Dromparis P, Webster L, Haromy A, Niven E, Maguire C, Gammer TL, Mackey JR, Fulton D, Abdulkarim B, McMurtry MS, Petruk KC. Sci Transl Med; 2010 May 12; 2(31):31ra34. PubMed ID: 20463368 [Abstract] [Full Text] [Related]
8. Targeting of EGFR increase anti-cancer effects of arsenic trioxide: Promising treatment for glioblastoma multiform. Mesbahi Y, Zekri A, Ahmadian S, Alimoghaddam K, Ghavamzadeh A, Ghaffari SH. Eur J Pharmacol; 2018 Feb 05; 820():274-285. PubMed ID: 29274334 [Abstract] [Full Text] [Related]
9. Complex I inhibition augments dichloroacetate cytotoxicity through enhancing oxidative stress in VM-M3 glioblastoma cells. Ward NP, Poff AM, Koutnik AP, D'Agostino DP. PLoS One; 2017 Feb 05; 12(6):e0180061. PubMed ID: 28644886 [Abstract] [Full Text] [Related]
13. Dichloroacetate induces cell cycle arrest in human glioblastoma cells persistently infected with measles virus: a way for controlling viral persistent infection. Takahashi M, Watari E, Takahashi H. Antiviral Res; 2015 Jan 05; 113():107-10. PubMed ID: 25433309 [Abstract] [Full Text] [Related]
14. Dichloroacetate, a selective mitochondria-targeting drug for oral squamous cell carcinoma: a metabolic perspective of treatment. Ruggieri V, Agriesti F, Scrima R, Laurenzana I, Perrone D, Tataranni T, Mazzoccoli C, Lo Muzio L, Capitanio N, Piccoli C. Oncotarget; 2015 Jan 20; 6(2):1217-30. PubMed ID: 25544754 [Abstract] [Full Text] [Related]
15. The combined effect of dichloroacetate and 3-bromopyruvate on glucose metabolism in colorectal cancer cell line, HT-29; the mitochondrial pathway apoptosis. Nikravesh H, Khodayar MJ, Behmanesh B, Mahdavinia M, Teimoori A, Alboghobeish S, Zeidooni L. BMC Cancer; 2021 Aug 07; 21(1):903. PubMed ID: 34364387 [Abstract] [Full Text] [Related]
16. Dichloroacetate induces apoptosis in endometrial cancer cells. Wong JY, Huggins GS, Debidda M, Munshi NC, De Vivo I. Gynecol Oncol; 2008 Jun 07; 109(3):394-402. PubMed ID: 18423823 [Abstract] [Full Text] [Related]
17. [Possible mechanism of the selective action of the inhibitors of glycolysis in the endothelial cells and the human carcinoma cells in the culture]. Giliano NY, Bondarev GN, Konevega LV, Noskin LA, Zhurishkina EV, Alchinova IB. Patol Fiziol Eksp Ter; 2014 Jun 07; (4):78-85. PubMed ID: 25980231 [Abstract] [Full Text] [Related]
18. Multi-modality imaging to assess metabolic response to dichloroacetate treatment in tumor models. Neveu MA, De Preter G, Joudiou N, Bol A, Brender JR, Saito K, Kishimoto S, Grégoire V, Jordan BF, Krishna MC, Feron O, Gallez B. Oncotarget; 2016 Dec 06; 7(49):81741-81749. PubMed ID: 28082726 [Abstract] [Full Text] [Related]
19. Metabolic targeting of EGFRvIII/PDK1 axis in temozolomide resistant glioblastoma. Velpula KK, Guda MR, Sahu K, Tuszynski J, Asuthkar S, Bach SE, Lathia JD, Tsung AJ. Oncotarget; 2017 May 30; 8(22):35639-35655. PubMed ID: 28410193 [Abstract] [Full Text] [Related]
20. Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells. Sun RC, Board PG, Blackburn AC. Mol Cancer; 2011 Nov 18; 10():142. PubMed ID: 22093145 [Abstract] [Full Text] [Related] Page: [Next] [New Search]